PROPEL: A multi-center phase 2 open-label study of pralatrexate (PDX) with vitamin B(12) and folic acid supplementation in patients with replapsed or refractory peripheral T-cell lymphoma Meeting Abstract


Authors: O'Connor, O. A.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Barlett, N.; Shustov, A.; Lechowicz, M. J.; Savage, K. J.; Coiffier, B.; Jacobsen, E.; Zinzani, P. L.; Goy, A.; Zain, J.; Wilroy, S.; Patterson, M.; Boyd, A.; Saunders, M. E.; Cagnoni, P.; Horwitz, S. M.
Abstract Title: PROPEL: A multi-center phase 2 open-label study of pralatrexate (PDX) with vitamin B(12) and folic acid supplementation in patients with replapsed or refractory peripheral T-cell lymphoma
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 103
Language: English
ACCESSION: WOS:000262104700262
PROVIDER: wos
PUBMED: 22276298
DOI: 10.1182/blood.V112.11.261.261
Notes: --- - Meeting Abstract: 261 - Oral Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz